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Formation of the mature 3 ends of the vast majority of cellular mRNAs occurs through cleavage and
polyadenylation and requires a cleavage and polyadenylation specificity factor (CPSF) containing, among other
proteins, CPSF-73 and CPSF-100. These two proteins belong to a superfamily of zinc-dependent -lactamase
fold proteins with catalytic specificity for a wide range of substrates including nucleic acids. CPSF-73 contains
a zinc-binding histidine motif involved in catalysis in other members of the -lactamase superfamily, whereas
CPSF-100 has substitutions within the histidine motif and thus is unlikely to be catalytically active. Here we
describe two previously unknown human proteins, designated RC-68 and RC-74, which are related to CPSF-73
and CPSF-100 and which form a complex in HeLa and mouse cells. RC-68 contains the intact histidine motif,
and hence it might be a functional counterpart of CPSF-73, whereas RC-74 lacks this motif, thus resembling
CPSF-100. In HeLa cells RC-68 is present in both the cytoplasm and the nucleus whereas RC-74 is exclusively
nuclear. RC-74 does not interact with CPSF-73, and neither RC-68 nor RC-74 is found in a complex with
CPSF-160, indicating that these two proteins form a separate entity independent of the CPSF complex and are
likely involved in a pre-mRNA processing event other than cleavage and polyadenylation of the vast majority
of cellular pre-mRNAs. RNA interference-mediated depletion of RC-68 arrests HeLa cells early in G1 phase,
but surprisingly the arrested cells continue growing and reach the size typical of G2 cells. RC-68 is highly
conserved from plants to humans and may function in conjunction with RC-74 in the 3 end processing of a
distinct subset of cellular pre-mRNAs encoding proteins required for G1 progression and entry into S phase.
In metazoans, there are two distinct mechanisms of 3 end
processing of pre-mRNAs that lead to formation of mature
mRNAs. The vast majority of pre-mRNAs are processed at the
3 end by a coupled cleavage and polyadenylation reaction (9,
57, 71, 78). However, the replication-dependent histone pre-
mRNAs are processed by a one-step mechanism that involves
only a cleavage reaction (13, 40, 47). Both mechanisms require
two cis-acting elements in the pre-mRNA and involve different
sets of trans-acting factors.
In mammalian pre-mRNAs, the cleavage and polyadenyla-
tion reaction occurs about 20 nucleotides downstream of a
highly conserved polyadenylation signal, AAUAAA. The AA
UAAA sequence is recognized by cleavage and polyadenyla-
tion specificity factor 160 (CPSF-160) (32, 49), which exists in
a stable complex with three other proteins, CPSF-100, CPSF-
73, and CPSF-30 (2, 4, 31, 33, 48). The CPSF complex also
contains a fifth component, Fip1, which may be only loosely
associated with the other subunits or which may exist in non-
equimolar amounts in the complex (34). The CPSF complex is
required for both cleavage and polyadenylation. About 30 nu-
cleotides downstream of the cleavage site there is a weakly
conserved GU-rich element, which is recognized by a three-
subunit cleavage stimulation factor (CstF) required for cleav-
age but not poly(A) addition (38). Two poorly characterized
multisubunit complexes, referred to as cleavage factor I (CF I)
and CF II, are also required for cleavage but not polyadenyl-
ation (59, 78). Efficient cleavage and polyadenylation addition-
ally require poly(A) polymerase (49).
Mammalian replication-dependent histone pre-mRNAs are
cleaved 5 nucleotides downstream of a highly conserved stem-
loop structure consisting of a 6-bp stem and a 4-nucleotide
loop. This processing results in the generation of mature his-
tone mRNAs that end with the stem-loop followed by an AC-
CCA single-stranded sequence. This unusual 3 end plays a key
role at the posttranscriptional level in coordinating histone
synthesis with DNA replication (40). A smaller group of his-
tone mRNAs transcribed from the replacement variant histone
genes are synthesized throughout the cell cycle (52). These
mRNAs are generated by a standard cleavage and polyadenyl-
ation mechanism. The stem-loop in replication-dependent hi-
stone pre-mRNA is recognized by the stem-loop binding pro-
tein (SLBP) (74), also known as the hairpin binding protein
(39). About 15 nucleotides downstream of the cleavage site
there is a short purine-rich sequence called the histone down-
stream element (HDE). This downstream sequence is recog-
nized by the U7 snRNP, which contains an 60-nucleotide U7
snRNA (46). Interaction of the U7 snRNP with the histone
pre-mRNA is mediated by base pairing between the HDE and
the 5 end of U7 snRNA (66). The U7 snRNP, in place of the
D1 and D2 Sm proteins present in the spliceosomal snRNPs,
contains two Sm-like proteins, Lsm10 (55) and Lsm11 (54).
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Lsm11 interacts with ZFP 100, a 100-kDa zinc finger protein
that bridges the U7 snRNP with the stem-loop/SLBP complex
(12, 54).
An important goal of recent studies on 3 end processing is
determining the identity of a protein that cleaves the phos-
phodiester bond in each type of pre-mRNA. Based on struc-
tural and sequence analyses, it has been recently proposed that
the cleavage preceding polyadenylation may be catalyzed by
CPSF-73 (1, 7). CPSF-73 belongs to a superfamily of metal-
dependent proteins with the -lactamase fold that includes
proteins with a broad range of biological activities and sub-
strate specificities (10). Among members of the -lactamase
superfamily are three recently characterized zinc-dependent
proteins with either proven or predicted endonuclease activity:
ELAC2, also referred to as tRNase Z, required for 3 end
maturation of eukaryotic tRNAs (21, 62, 67) and linked to a
hereditary form of prostate cancer (68); SNM 1, involved in
DNA cross-link repair (20); and Artemis, involved in V(D)J
recombination and DNA double-strand break repair (36, 45).
SNM 1 and Artemis, the two DNA-specific proteins, share a
domain with CPSF-73 and CPSF-100, called the -CASP do-
main (7). The majority of proteins of the -lactamase super-
family, including CPSF-73, contain the conserved zinc binding
motif HXHXDH (where X indicates any amino acid), which
plays a central role in catalysis (42, 73). CPSF-73 exists in the
five-subunit CPSF complex with another member of the -lac-
tamase superfamily, CPSF-100. CPSF-100, in contrast to
CPSF-73, has substitutions within the histidine motif and thus
is unlikely to play a direct role in catalysis. Involvement of
CPSF-73 in cleaving pre-mRNAs prior to addition of the
poly(A) tail is supported by recent studies demonstrating that
a protein with a molecular size consistent with that of CPSF-73
can be UV-cross-linked to pre-mRNA in the vicinity of the
cleavage site (60).
Here we describe the identification and preliminary charac-
terization of two unknown members of the -lactamase protein
superfamily, RC-68 and RC-74, which have sequence similarity
with CPSF-73 and CPSF-100 and which belong to the -CASP
family. RC-68 and RC-74 interact with each other in HeLa and
mouse cells but do not associate with subunits of the CPSF
complex. We demonstrate that depletion of RC-68 by RNA
interference (RNAi) results in the arrest of HeLa cells in G1
phase, suggesting a link between this putative RNA processing
factor and cell cycle regulation.
MATERIALS AND METHODS
Cloning. Full-length cDNAs encoding CPSF-73, CPSF-100, RC-68, and RC-74
were obtained from ATCC (Manassas, Va.) and subcloned into appropriate
vectors with PCR-generated fragments containing the desired restriction sites.
Subcellular localization. The cDNAs for CPSF-73, RC-68, and RC-74 were
inserted in frame into pEGFP-N1 vector (BD Biosciences) upstream of the
region encoding green fluorescent protein (GFP) and transfected into HeLa cells
with Lipofectamine 2000 (Invitrogen). The intracellular distribution of the fusion
proteins was visualized by fluorescence microscopy 24 h after transfection. For
immunostaining, HeLa cells stably expressing the hemagglutinin (HA)-tagged
RC-68 or RC-74 were fixed with 3.7% formaldehyde and permeabilized with
0.5% Triton X-100. The tagged proteins were detected with an anti-HA antibody
and a Cy3-conjugated goat anti-mouse antibody.
Histone pre-mRNA processing. Preparation of mammalian and Drosophila
melanogaster nuclear extracts and histone pre-mRNA processing were carried
out as previously described (15, 17, 19, 41).
RNAi experiments. Expression of RC-68 was downregulated in HeLa cells by
a double-hit protocol, as described previously (70). Cells were collected 48 h after
the second small interfering RNA (siRNA) transfection. Chemically synthesized
siRNAs were obtained from Dharmacon (Lafayette Colo.) and had the following
sequences of the top strand: 5AGCACAUCAAGGCCUUCGAdTdT3 (RC-68
specific 1), 5ACGAAAAGAACAUGGUCAUdTdT3 (RC-68 specific 2), and
5GGUCCGGCUCCCCCAAAUGdTdT3 (control). A portion of cells were
lysed in a buffer containing 150 mM NaCl, 50 mM Tris-HCl (pH 8), 10 mM
sodium azide, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 1
protease inhibitor mixture (Sigma), and 0.5% NP-40 and analyzed by Western
blotting. The remaining cells were fixed with 70% ethanol and stained with
propidium iodide, and 104 cells were analyzed for their DNA content by flow
cytometry with a FACscan and the Summit software (Cytomation, Inc.).
The yeast two-hybrid system. A HeLa cDNA library was screened against
RC-74 fused to the GAL4 DNA binding domains as described previously (14).
The transformants were plated on selective plates containing 2.5 mM 3-amino-
triazole (3-AT), and fast-growing colonies were subsequently tested on plates
containing up to 100 mM 3-AT.
Cell synchronization. HeLa cells were synchronized by a double thymidine
block and collected at different time points after release from the block, as
described previously (75).
Antibodies. Rabbit antibodies against the C-terminal peptides of mouse RC-68
(SFLTTLLKNGLPQAPS) and mouse RC-74 (LRVRLRDLVLRFLQKF) were
generated. Anti-RC-68 and anti-RC-74 were affinity purified on a Sulfolink
column (Pierce) as recommended by the manufacturer. Each antibody recog-
nizes both the mouse and human proteins.
Coimmunoprecipitation of RC-74 and RC-68. The full-length cDNA for
human RC-74 was cloned into a pcDNA 3-HA vector and stably expressed in
HeLa cells as a fusion protein with two HA tags on the N terminus (HA/RC-
74). The cells from 10 15-cm-diameter plates (about 1 ml of packed cell
volume) were lysed in 10 ml of the NP-40 lysis buffer (see above), and cell
debris was removed by centrifugation at 12,000 g for 10 min. The lysate was
incubated for 3 h with 20 l of a monoclonal anti-HA antibody (Covance),
followed by a 2-h incubation with 40 l of protein G-Sepharose beads (Am-
ersham). The beads were washed for 2 h with the NP-40 lysis buffer and
divided into two equal portions, which were used for Western blotting with
either the anti-HA antibody or the affinity-purified anti-RC-68. To immuno-
precipitate the HA/RC-74 from a nuclear extract, HeLa cells expressing
HA/RC-74 were collected from 20 15-cm-diameter plates and used to prepare
nuclear extract as previously described (15, 41). The nuclear extract was not
dialyzed against buffer D (20 mM HEPES-KOH [pH 7.9], 100 mM KCl, 0.5
mM dithiothreitol, 0.2 mM EDTA, 20% glycerol); instead it was adjusted to
100 mM KCl by adding a buffer with the same composition as buffer D but
lacking KCl. The nuclear extract was divided in two portions, and each was
used for immunoprecipitation with either anti-HA or anti-FLAG (Sigma) as
a negative control. The subsequent steps were carried out as described above
with the difference that protein G-Sepharose beads were washed with buffer
D instead of NP-40 lysis buffer. Mouse RC-68 was precipitated from 250 l
of a dialyzed nuclear extract from mouse myeloma cells with 25 l of the
anti-RC-68 antibody. The immunoprecipitates collected on protein A-agar-
ose beads were tested for the presence of RC-74 and CPSF-160 by Western
blotting.
RESULTS
Identification of RC-68 and RC-74. The hydrolytic activity of
several zinc-dependent proteins with the -lactamase fold on
nucleic acids brought our attention to previously uncharacter-
ized members of this family. By searching the available data-
bases, we identified two unknown human proteins of 68 and 74
kDa with sequence similarity to CPSF-73 and CPSF-100, des-
ignated here RC-68 and RC-74 (for proteins of 68 and 74 kDa
related to CPSF subunits). RC-68 (NP_060341, AAH07978,
CAB66747) contains 600 amino acids (Fig. 1A) and is 40%
identical to CPSF-73 throughout the first 450 amino acids (Fig.
1B) and 25% identical to CPSF-100 throughout the first 400
amino acids. RC-68, like CPSF-73, contains within the N-ter-
minal region the sequence HFHLDH, conforming to the his-
tidine motif consensus, HXHXDH, which in other proteins of
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the -lactamase superfamily is involved in zinc binding and
catalysis (73). The sequences of the first 450 amino acids in
RC-68 and CPSF-73 have been highly conserved during evo-
lution, consistent with the N-terminal domain in both proteins
being involved in catalysis. For example, the N-terminal do-
main in human RC-68 is 80% identical to the Drosophila or-
thologue (NP_651721, AAF56931, AAL28645) and 55% iden-
tical to the recently described Arabidopsis thaliana orthologue
(NP_178282, AAN87883) designated AtCPSF73-II (76).
RC-74 (NP_060720, BAA91867, AAH25267) is a 658-ami-
no-acid polypeptide (Fig. 1C) and within the N-terminal region
has about 20% identity to RC-68, CPSF-73, and CPSF-100
(Fig. 1D). RC-74, like CPSF-100, contains mutations within
the histidine motif, suggesting that it is inactive in catalysis
(Fig. 1E). RC-74 has been conserved during evolution to a
significantly lesser extent than CPSF-73 and RC-68. Human
RC-74 has 51% identity to the Drosophila orthologue (NP_
648838, AAL13803, AAF49538) and 26% identify to the Ara-
bidopsis orthologue (NP 187409) throughout most of the pro-
tein. Interestingly, the lack of the histidine motif is an evolu-
tionarily conserved feature of all RC-74 orthologues.
Intracellular localization of RC-68 and RC-74. To deter-
mine the in vivo localization of RC-68 and RC-74, each protein
was fused at the C terminus to GFP and transiently expressed
in HeLa cells. The intracellular distribution of the fusion pro-
teins was analyzed by fluorescence microscopy. For compari-
son, we also determined the intracellular localization of
CPSF-73 fused to GFP. The RC-68 fusion protein was present
in both the nucleus and the cytoplasm, with a higher concen-
tration detected in the nucleus (Fig. 2A). Interestingly,
CPSF-73 fused to GFP was also detected in both cellular com-
partments. In contrast, the RC-74 fusion protein was exclu-
sively nuclear (Fig. 2A). To confirm these results, we trans-
fected HeLa cells with a cDNA construct encoding either
RC-68 or RC-74 fused at the N terminus with two HA tags.
The intracellular distribution of the stably expressed tagged
proteins was determined by immunostaining with the anti-HA
antibody and the Cy3-conjugated goat anti-mouse antibody.
FIG. 1. RC-68 and RC-74 are members of the -lactamase protein superfamily related to CPSF-73 and CPSF-100. (A) Amino acid sequence
of RC-68 with the conserved zinc binding motif underlined. (B) Pairwise alignment of RC-68 (top) and CPSF-73 (bottom) with BLASTP.
(C) Amino acid sequence of RC-74 with the degenerate histidine motif underlined. (D) Identities (Id) and similarities (Si) between the indicated
regions of the four members of the -lactamase superfamily. (E) Alignment of RC-68 (top) with the three other members of the -lactamase
superfamily (bottom) within the region containing the histidine motif or its degenerate form.
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The HeLa cells were simultaneously stained with DAPI (4,6-
diamidino-2-phenylindole) to visualize nuclei. The intracellu-
lar localization of the HA-tagged proteins was virtually iden-
tical with the localization of the GFP fusion proteins: HA-
tagged RC-68 was detected in both cellular compartments, and
HA-tagged RC-74 was detected only in the nuclei (Fig. 2B).
Interaction between RC-74 and RC-68. To gain some insight
into possible functions of RC-74, we searched for its interact-
ing protein partners. We constructed a yeast strain expressing
a fusion protein consisting of the GAL4 DNA binding domain
and the full-length RC-74 and carried out a yeast two-hybrid
screen with a HeLa cDNA library. Out of 4 million yeast
transformants we isolated more than 10 rapidly growing colo-
nies, all of which expressed C-terminal fragments of RC-68.
The shortest and the longest RC-68 inserts encoded the last
124 and 214 amino acids, respectively, while the intermediate-
size insert encoded a 171-amino-acid portion of RC-68. In
addition to the various C-terminal portions of RC-68, we also
isolated several yeast clones expressing full-length importin ,
which together with importin  is involved in importing pro-
teins from the cytoplasm to the nucleus (26, 27). All the RC-68
clones grew rapidly in the presence of 100 mM 3-AT, indicative
of a very strong interaction, while the clones containing im-
portin  grew at a lower rate on 50 mM 3-AT and did not grow
in the presence of 100 mM 3-AT (Fig. 3A). We conclude that
the last 124 amino acids of RC-68 are sufficient to mediate
interaction with RC-74.
To test whether RC-68 and RC-74 interact in mammalian
cells, we used a coimmunoprecipitation assay. Since the rabbit
antibody against the C-terminal peptide of RC-74 was ineffi-
cient in precipitating the protein from cell extracts, we used
HeLa cells stably expressing the HA-tagged RC-74 and the
anti-HA antibody. The cells were lysed in 0.5% NP-40 lysis
buffer, and the lysate was incubated with the anti-HA antibody.
The HA immunoprecipitates were divided into two equal por-
tions and tested by Western blotting for the presence of either
the HA-tagged RC-74, with the anti-HA antibody, or endog-
enous RC-68, with a rabbit antibody against the C-terminal
peptide of RC-68. As a negative control we used HeLa cells
stably expressing HA-tagged 3hExo (16). The anti-RC-68 an-
tibody detects RC-68 migrating at 65 kDa and a cross-reacting
protein migrating at 48 kDa (Fig. 3B, lanes 5 and 6). Western
blotting with the anti-HA antibody indicates that HA/3hExo
was expressed at about a threefold-higher level than HA/
RC-74 (Fig. 3B, lanes 1 and 2, respectively; a band correspond-
ing to the HA/RC-74 is more visible on longer exposures).
Judging from the amount of HA/RC-74 and HA/3hExo re-
maining in the supernatants after incubation of the lysates with
anti-HA and protein G-Sepharose, the efficiency of immuno-
precipitation of each protein was about 50% (not shown). The
anti-HA antibody did not precipitate detectable amounts of
endogenous RC-68 from the cell extract containing HA-tagged
3hExo (Fig. 3B, lane 7). The same antibody incubated with
cell extract containing HA-tagged RC-74 coprecipitated signif-
icant amounts of RC-68 but not the cross-reacting protein
migrating at 48 kDa (Fig. 3B, lane 8). We used a reciprocal
approach and tested the ability of the anti-RC-68 antibody to
coprecipitate RC-74 from a nuclear extract prepared from
FIG. 2. Intracellular localization of RC-68, CPSF-73, and RC-74. (A) RC-68, CPSF-73, and RC-74 were expressed in HeLa cells as fusion
proteins with the C-terminal GFP (top), and the intracellular distribution of the fusion proteins was analyzed by fluorescence microscopy.
(B) Intracellular distribution of the HA-tagged RC-68 (top) and RC-74 (bottom) detected by immunostaining. The nuclei were visualized by
staining with DAPI. HA, anti-HA.
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mouse myeloma cells. As shown in Fig. 3C the antibody spe-
cifically precipitated RC-68 from the mouse nuclear extract
(top, lane 3) and coprecipitated significant amounts of RC-74
(bottom, lane 3). A nonspecific antibody used as a negative
control was unable to precipitate any detectable amounts of
each protein (Fig. 3C, lane 2). Similar results were obtained
with nuclear extracts from HeLa cells (Fig. 4C, lane 2). These
results, together with the results of the yeast two-hybrid screen,
demonstrate that RC-68 and RC-74 interact with each other
and form a stable complex in the nuclei of mammalian cells.
RC-68 and RC-74 do not interact with CPSF-160. To deter-
mine the specificity of the interaction between RC-74 and
RC-68, we incubated the blot shown in Fig. 3B (lanes 5 to 8)
with an antibody against CPSF-73 (kindly provided by D. Bent-
ley, University of Colorado). The anti-CPSF-73 specifically
recognizes CPSF-73 migrating at about 75 kDa in HeLa lysates
expressing either HA/RC-74 or HA/3hExo (Fig. 4A, lanes 1
and 2). However, CPSF-73 was not detected in the HA pre-
cipitates containing HA tagged RC-74 (Fig. 4A, lane 4), indi-
cating that these two proteins do not interact in HeLa cells.
While it has been known for over 10 years that CPSF-73 and
CPSF-100 exist together in the CPSF complex (2, 4, 31, 33, 48),
it has not been previously established whether the two proteins
directly interact with each other or exist in the same complex
through interaction with other CPSF subunits. CPSF-73 and
RC-68 are 40% identical throughout the first 450 amino acids
(Fig. 1B) but do not have any sequence similarity within the
C-terminal region. The yeast two-hybrid system revealed that
the C-terminal region of RC-68 strongly interacts with the
full-length RC-74, raising the possibility that the same region
of CPSF-73 is involved in interaction with CPSF-100. We
tested this hypothesis by using the directed yeast two-hybrid
system. A portion of CPSF-73 encompassing amino acids 440
to 684 (the last few amino acids of the N-terminal domain and
the entire C-terminal region) was expressed in yeast cells as a
fusion protein with the N-terminal GAL4 activation domain
and tested for interaction with the full-length CPSF-100 or
RC-74, each fused to the GAL4 DNA binding domain.
CPSF-73 has a longer C terminus than RC-68; thus the tested
fragment of CPSF-73 consisted of 245 amino acids rather than
171 amino acids as does the C-terminal region of RC-68. Since
the full-length cDNA for human CPSF-100 was not available,
we instead cloned mouse CPSF-100, which is nearly identical
to the human protein. The strength of the interaction was
determined by analyzing the ability of yeast cells expressing
both fusion proteins to grow on different concentrations of
3-AT. As shown in Fig. 4B, the interaction between the C-
terminal region of CPSF-73 and the full-length CPSF-100 re-
sulted in rapid growth of yeast cells in the presence of 25 mM
3-AT and slower growth in the presence of 50 mM AT. The
highest concentration of 3-AT (100 mM) almost completely
inhibited growth, indicating that the interaction between the
two subunits of the CPSF complex is not as strong as the
interaction between RC-74 and the C-terminal domain of RC-
68, which allows yeast cells to rapidly grow under the restrictive
conditions of 100 mM 3-AT. Shortening the length of the
C-terminal region of CPSF-73 from 245 to 206 amino acids
reduced the strength of the interaction but did not abolish it
(not shown). Importantly, the yeast cells expressing the last 245
amino acids of the CPSF-73 and the full-length RC-74 were
not able to grow in the presence of 10 mM 3-AT, confirming
that these two proteins do not interact with each other (Fig.
4B).
We considered the possibility that the RC-68/RC-74 dimer is
FIG. 3. RC-68 and RC-74 interact in the yeast two-hybrid system
and in mammalian cells. (A) Two yeast clones isolated in the yeast
two-hybrid system as interacting with the full-length RC-74 as bait, one
expressing the last 171 amino acids of RC-68 (top row) and the other
expressing full-length importin  (bottom row), were tested for growth
in the presence of histidine or increasing concentrations of 3-AT.
(B) Cell lysates from HeLa cells stably expressing HA-tagged 3hExo
(lanes 1 and 5) or HA-tagged RC-74 (lanes 2 and 6) were incubated
with the anti-HA (-HA) antibody and protein G-Sepharose. The
immunoprecipitates (IP) were tested by Western blotting for the pres-
ence of the HA-tagged proteins with anti-HA (lanes 3 and 4) or for the
presence of RC-68 with an antibody against the C-terminal peptide
(lanes 7 and 8). The amounts of the lysates analyzed in lanes 1 and 2
and 5 and 6 represent 0.25% of the input used for immunoprecipita-
tion. Migration of molecular size markers of 90 and 50 kDa is indicated
at the right. Asterisk, 48-kDa protein that cross-reacts with the anti-
body against RC-68. (C) A dialyzed nuclear extract (NE) from mouse
myeloma cells (lane 1) was incubated with either a nonspecific anti-
body (lane 2) or with anti-RC-68 (lane 3), and the precipitates were
tested by Western blotting for the presence of RC-68 (top) or RC-74
(bottom) with anti-RC-68 or anti-RC-74, respectively. The amount of
the nuclear extract analyzed in lane 1 represents 5% of the input used
for immunoprecipitation. A band visible below RC-68 in the precipi-
tated samples (lanes 2 and 3) represents the heavy chain of immuno-
globulin, which interacts with the secondary antibody.
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exchangeable with the CPSF-73/CPSF-100 dimer and by inter-
acting with CPSF-160 forms an alternative CPSF complex in-
volved in the 3 end processing of a subset of pre-mRNAs. To
test this hypothesis, we prepared nuclear extract from HeLa
cells and used anti-RC-68 to precipitate RC-68 and associated
proteins. We used a nuclear extract rather than a whole-cell
lysate made with NP-40 to assure that processing factors
present in HeLa cells remain intact. Since it has been reported
that prolonged dialysis against buffer D containing 0.2 mM
EDTA leads to gradual loss of activity, which could indicate
disruption of processing factors (60), the nuclear extract was
not dialyzed and instead adjusted to 100 mM KCl by adding
buffer D lacking any salt. The anti-RC-68 antibody precipitated
significant amounts of RC-68 from the nuclear extract (Fig. 4C,
top, lane 2). As detected by Western blotting RC-74 was co-
precipitated with RC-68 (Fig. 4C, middle, lane 2). We tested
the same immunoprecipitates for the presence of CPSF-160
using anti-CPSF-160. The antibody (kindly provided by W.
Keller, University of Basel) detected CPSF-160 in an aliquot of
the nuclear extract from HeLa cells (Fig. 4C, bottom, lane 1)
but not in the RC-68 precipitates collected from a 20-fold-
larger amount of the extract (Fig. 4C, bottom, lane 2). We
repeated this experiment with a dialyzed mouse nuclear extract
and also did not observe any CPSF-160 in the RC-68 precipi-
tates (not shown). Since it was possible that the anti-RC-68
very inefficiently precipitates the RC-68/RC-74 dimer when
associated with CPSF-160, we also prepared a nondialyzed
nuclear extract from HeLa cells stably expressing the HA
tagged RC-74 and used the anti-HA to precipitate HA/RC-74
and associated proteins. As a negative control in the immuno-
precipitation we used an anti-FLAG antibody. The anti-HA
and the anti-FLAG precipitates were tested for the presence of
RC-68 and CPSF-160 by Western blotting with antibodies spe-
cific to each protein. Only background amounts of each protein
were detected in the anti-FLAG immunoprecipitates (Fig. 4D,
lane 2). However, the anti-HA specifically coprecipitated
RC-68 but not CPSF-160, further supporting the notion that
the RC-68/RC-74 dimer does not form a complex with this
CPSF subunit (Fig. 4D, lane 3). We conclude that collectively
these experiments argue against the possibility that RC-68 and
RC-74 form a complex with CPSF-160.
Depletion of RC-68 in HeLa cells by siRNA. We used RNAi
to reduce the in vivo level of RC-68 in HeLa cells to determine
whether it plays an essential role in the cell. A specific siRNA
directed to the RC-68 mRNA reproducibly reduced expression
of RC-68 in HeLa cells to about 5% of its normal level (Fig. 5A
and 6A, lane 2) but did not affect the level of the cross-reacting
protein migrating at 48 kDa. During the entire treatment time
FIG. 4. RC-68 and RC-74 do not associate with subunits of the CPSF complex. (A) The blot shown in Fig. 3B (lanes 5 to 8) was stripped and
incubated with anti-CPSF-73. A weak band corresponding to RC-68 and visible in lane 4 is due to incomplete stripping of the anti-RC-68 from
the blot. IP, immunoprecipitates. (B) The ability of the last 245 amino acids of CPSF-73 fused to the GAL4 DNA binding domain to interact with
the full-length CPSF-100 or RC-74 was assayed with a directed two-hybrid system in the presence of histidine or in the absence of histidine plus
increasing concentrations of 3-AT. (C) A nondialyzed nuclear extract (NE) from HeLa cells (lane 1) was incubated with anti-RC-68 (lane 2), and
the precipitates were tested for the presence of RC-68 (top), RC-74 (middle), and CPSF-160 (bottom) with anti-RC-68 (-RC-68), anti-RC-74,
and anti-CPSF-160, respectively. Asterisk, HeLa protein cross-reacting with anti-RC-74. The amount of the nuclear extract analyzed in lane 1
represents 5% of the input used for immunoprecipitation. (D) A nondialyzed nuclear extract from HeLa cells stably expressing the HA/RC-74
fusion protein (lane 1) was incubated with either anti-FLAG (lane 2) or anti-HA (lane 3), and the precipitates were tested for the presence of
RC-68 (top) and CPSF-160 (bottom) with anti-RC-68 and anti-CPSF-160, respectively. The amount of the nuclear extract analyzed in lane 1
represents 2.5% of the input used for immunoprecipitation.
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the cells showed very limited cell division and by the end of the
treatment had ceased to divide. A second siRNA targeted to a
different region of the RC-68 mRNA produced a comparable
reduction of RC-68 expression, leading to the same phenotypic
changes (not shown), while a control siRNA had no effect (Fig.
5A and 6A, lane 1). As determined by flow cytometry, at least
90% of cells treated with the specific siRNA were arrested in
G1 while HeLa cells treated with a control siRNA displayed
the typical cell cycle profile, with about 60% of cells in G1 (Fig.
5B). Visually, cells treated with RC-68 siRNAs appeared sig-
nificantly larger than control siRNA-treated cells. Flow cytom-
etry analysis demonstrated that the G1-arrested cells were the
size of G2 cells (Fig. 5C), indicating that depletion of RC-68
does not prevent cell growth although it does block entry into
S phase.
To determine whether the cells were arrested early or late in
G1 phase, we analyzed an extract from cells depleted of RC-68
for the presence of SLBP, a cell cycle-regulated protein in-
volved in controlling histone mRNA metabolism. SLBP accu-
mulates during late G1 phase and is degraded at the end of S
phase (75). Since the concentration of SLBP in the cells de-
pleted of RC-68 was also reduced over 95% (Fig. 6A, lane 2),
we conclude that the cells were arrested early in G1 phase. The
levels of two proteins constitutively expressed during the cell
cycle, a novel zinc finger protein migrating at 90 kDa (our
unpublished results) and 3hExo, migrating at 50 kDa (16),
were comparable to those in the control cells (Fig. 6B). Among
five proteins tested with commercially available antibodies, the
levels of Bcl-2 and AMPK were also unaffected by depletion
of RC-68 while p53, p21, and cyclin D1, normally expressed at
the highest level in G1 cells (64), were clearly more abundant
in the treated cells (Fig. 6B).
To determine whether cell cycle arrest of HeLa cells de-
pleted of RC-68 is a consequence of cell cycle regulation of
RC-68 itself, we analyzed the level of this protein in whole-cell
and nuclear lysates prepared from synchronized HeLa cells.
HeLa cells were collected at different time points after release
from the double thymidine block and tested by Western blot-
ting for the presence of RC-68 and SLBP. We determined that
RC-68 is expressed at similar levels throughout the cell cycle
(Fig. 6C and data not shown). As expected, the level of SLBP
remained constant as cells progressed through S phase and
rapidly declined at the S/G2 boundary. We also tested expres-
sion of RC-74 during the cell cycle by measuring the level of
both the endogenous protein using anti-RC-74 (Fig. 6D, lanes
1 to 6) and stably expressed HA-tagged RC-74 using the an-
ti-HA antibody (Fig. 6D, lanes 7 to 12). Expression of this
protein also did not change significantly during the cell cycle,
while SLBP showed its normal profile of expression, with the
highest accumulation in S phase.
DISCUSSION
RC-68 and RC-74 form a complex separate from the CPSF
complex. We identified two unknown human proteins, RC-68
and RC-74, with high similarity to CPSF-73 and CPSF-100 and
demonstrated that they form a complex in HeLa cells and
mouse myeloma cells. In HeLa cells RC-74 has virtually exclu-
sive nuclear localization whereas RC-68, in addition to being
present in the nucleus, is also present in the cytoplasm. All four
proteins belong to the -lactamase superfamily of metal-de-
pendent hydrolases. RC-68 contains the histidine motif typical
of all active proteins of the superfamily and is most similar to
CPSF-73, while RC-74 lacks the motif and hence seems to be
a counterpart of CPSF-100. The existence of two complexes in
human cells, CPSF-73/CPSF-100 and RC-68/RC-74, each con-
sisting of a protein containing the typical histidine motif and
another protein lacking this motif, is striking and suggests that
this structural organization plays an important role in the func-
tion of each complex. It is possible that, while CPSF-73 and
RC-68 are predicted to contain the active site within each
FIG. 5. RNAi-mediated downregulation of RC-68 results in arrest
of HeLa cells in G1 phase. (A) RC-68 expression in HeLa cells treated
with either a control siRNA (lane 1) or a specific siRNA targeted to
RC-68 (lane 2). Asterisk, 48-kDa protein that cross-reacts with the
antibody against RC-68. (B) Analysis of HeLa cells treated with either
a control siRNA (left) or a specific siRNA targeted to RC-68 (right) by
flow cytometry. x and y axes, DNA content and cell number, respec-
tively. The percentages of cells in each phase of the cell cycle are
indicated. (C) Shift in the average sizes of cells in the control popu-
lation and in the population of cells depleted of RC-68. x and y axes,
forward scatter (indicative of the cell size) and cell number, respec-
tively.
VOL. 25, 2005 CPSF-73 HOMOLOGUE REQUIRED FOR CELL CYCLE PROGRESSION 1495
complex, they may require association with another protein of
the -lactamase fold, in which the histidine motif has been
disrupted, to adopt a unique structural arrangement important
for catalysis. Interestingly, ELAC2, a -lactamase fold protein
involved in 3 end processing of eukaryotic pre-tRNAs, con-
tains two related sequences in a single polypeptide, one con-
taining the catalytically active histidine motif and the other
lacking the histidine motif but retaining similarity in the flank-
ing sequences (68). Further studies will be required to deter-
mine the functional significance of such an organization and
the role played in each complex by the inactive -lactamase
domain. The orthologues of RC-68 and RC-74 are easily iden-
tifiable in all known genomes of plants and animals, but not in
fungi. It is likely that the interaction of RC-68 and RC-74 is not
limited to human cells and also occurs in all organisms where
the two proteins exist.
Using the yeast two-hybrid system we demonstrated that the
region of RC-68 interacting with RC-74 is located within the
last 124 amino acids. The corresponding region of CPSF-73 is
involved in its interaction with CPSF-100 although formation
of a stronger complex between the two proteins may require
additional portions of CPSF-73 and/or contribution from the
three remaining CPSF subunits. The C-terminal regions in
RC-68 and CPSF-73 do not have any sequence similarity, and
we did not observe any interaction between RC-74 and the
C-terminal region of CPSF-73 in the directed yeast two-hybrid
system. In addition, we did not detect CPSF-73 in the immu-
noprecipitates of the HA-tagged RC-74. These results demon-
strate that RC-74 and CPSF-73 do not form a mixed pair and
also suggest that formation of such a pair between CPSF-100
and RC-68 is unlikely. Immunoprecipitation experiments using
both anti-RC-68 and anti-HA demonstrated that the RC-68/
RC-74 dimer does not exist in a complex with the largest
subunit of the CPSF complex, CPSF-160. Altogether, these
results indicate that RC-68 and RC-74 form a specific complex
that is independent of the CPSF subunits and that likely plays
a role in a process other than the cleavage and polyadenylation
of typical cellular pre-mRNAs.
RC-68 is required for cell cycle progression. Depletion of
the intracellular pool of RC-68 by RNAi arrested HeLa cells in
G1 phase. HeLa cells are known for their inherent inability to
arrest the cell cycle due to frequent activation of alternative
bypass pathways. Therefore, the rapid arrest of HeLa cells due
to depletion of RC-68 was unexpected and demonstrated that
RC-68 plays a critical role in cell cycle regulation. The most
likely hypothesis is that reduction of the cellular concentration
of RC-68 activates a checkpoint response that allows the RC-
68-depleted cells to complete the cell cycle but that prevents
them from progressing beyond G1 phase. Unlike cells arrested
by aphidicolin or the double thymidine block (75), the cells
depleted of RC-68 did not contain SLBP, suggesting that they
had arrested relatively early in G1. Even more unexpectedly,
depletion of RC-68 did not inhibit growth of HeLa cells, which
reached the size typical of G2 cells. Normally, cell growth is
required for subsequent progression through the cell cycle, and
in cultured cells growth and cell cycle progression are coupled
(29). A similar phenotype in which cell growth is uncoupled
from cell division was previously observed in untransformed
liver cells, with conditional deletion of 40S ribosomal protein
S6 (69). Depletion of RC-68 resulted in the accumulation of
FIG. 6. (A and B) Expression of selected proteins in RC-68-depleted HeLa cells. Cell lysates prepared from HeLa cells treated with either the
control siRNA (lane 1) or the siRNA specific to RC-68 (lane 2) were analyzed by Western blotting with various antibodies. Asterisk, 48-kDa
protein interacting with anti-RC-68. (C and D) Whole-cell extracts from HeLa cells synchronized by a double thymidine block were analyzed by
Western blotting for RC-68 (C, lanes 1 to 7), RC-74 (D, lanes 1 to 6), or the HA-tagged RC-74 (D, lanes 7 to 12) with anti-RC-68, anti-RC-74,
or anti-HA, respectively. Cell cycle regulation of SLBP was analyzed with anti-SLBP.
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the G1 regulatory proteins, cyclin D1 and the cyclin-dependent
kinase (cdk) inhibitor, p21 (64). The increased level of cyclin
D1 is consistent with the finding that in Drosophila this protein
is primarily involved in cell growth and not cell cycle regulation
(11, 23, 43). There are also reports that cyclin D is required for
growth of hepatocytes (50) and for cardiac hypertrophy (6).
The increased level of the cdk inhibitor p21 in the RC-68-
depleted cells is consistent with the failure of these cells to
progress through G1 and enter S phase. Interestingly, RNAi-
mediated silencing of CPSF-73 did not affect the cell cycle of
the treated cells but instead significantly reduced their growth
rate, further indicating that CPSF-73 and RC-68 play different
roles in the cell (8).
Possible roles for RC-68 and RC-74. RC-68 and CPSF-73, in
the first 450 amino acids, have 40% identity and 60% similarity,
and both contain the histidine motif and so-called -CASP
domain typical of a small group of proteins of the -lactamase
superfamily acting on nucleic acids (7). This group includes
Artemis, a protein involved in V(D)J recombination and DNA
double-strand break repair (45). Artemis in vitro displays 5-
to-3 exonuclease activity and in complex with the DNA-de-
pendent protein kinase catalytic subunit acquires endonuclease
activity (36). Mutations of the critical residues of the histidine
motif and the -CASP domain predicted to play a role in metal
binding and catalysis abolish the in vivo function of Artemis
and endonuclease activity in vitro (53, 56). Some of these
residues were found to also be essential for the in vivo activity
of CPSF-73 (60) and another member of the -CASP family,
SNM1, involved in DNA interstrand cross-link repair (35).
Although the definitive evidence is missing, the presence of the
histidine motif and the -CASP domain (7) and recent cross-
linking studies (60) strongly implicate CPSF-73 as the 3 en-
donuclease cleaving pre-mRNAs prior to addition of the
poly(A) tail.
The cellular roles for RC-68 and RC-74 remain unknown,
and it is possible that the RC-68/RC-74 complex functions in a
process unrelated to RNA metabolism and that the involve-
ment in cell cycle regulation is the only role played by RC-68.
However, the strong similarity of RC-68 and RC-74 to
CPSF-73 and CPSF-100 suggests that the two new proteins
play a role equivalent to that of the CPSF complex and form a
distinct endonuclease involved in the 3 end processing of a
subset of pre-mRNAs encoding proteins required for cell cycle
progression. There are at least three groups of potential pre-
mRNA substrates for RC-68 and RC-74. First, the two pro-
teins may be a part of an alternative CPSF complex containing
CPSF-160 and involved in 3 end processing of a special subset
of the AAUAAA-containing pre-mRNAs. However, since our
experiments did not detect any CPSF-160 in immunoprecipi-
tates containing both RC-68 and RC-74, we consider this hy-
pothesis rather unlikely. The second group of potential sub-
strates for RC-68 and RC-74 could consist of pre-mRNAs
lacking the AAUAAA polyadenylation signal or its sequence
variants recognizable by CPSF-160. These pre-mRNAs are
found in mammalian cells with a frequency much higher than
previously anticipated and may represent as many as 10% of all
cellular pre-mRNAs (3, 28, 37, 77). RC-68 and RC-74 could
form a complex with a functional equivalent of CPSF-160 ca-
pable of recognizing some structural features present in the
pre-mRNAs lacking AAUAAA. The third possibility is that
the RC-68/RC-74 complex is involved in 3 end processing of
replication-dependent histone pre-mRNAs and therefore plays
an essential role in synthesis of histone proteins.
Do RC-68 and RC-74 function as the endonuclease in 3 end
processing of histone pre-mRNAs? Since synthesis of histones
is required for entry into S phase (22, 51), the hypothesis that
RC-68 and RC-74 are responsible for cleaving replication-
dependent histone pre-mRNAs provides a logical explanation
for G1 arrest upon depletion of RC-68. The 3 end cleavage
coupled to polyadenylation and 3 end cleavage of histone
pre-mRNAs, despite many differences in composition of pro-
cessing signals and trans-acting factors, have several striking
similarities, suggesting involvement of related cleavage factors.
These similarities include preferred cleavage of both pre-
mRNA types after a CA between two closely spaced sequence
elements and subsequent generation of a family of downstream
products differing in the location of the 5 end rather than a
single product with the 5 end corresponding to the cleavage
site (24, 61, 63, 71). In 3 end processing of histone pre-
mRNAs generation of these downstream products results from
activity of a 5-to-3 exonuclease associated with the processing
machinery (72), and the same mechanism may be responsible
for trimming the downstream cleavage product in 3 end pro-
cessing of nonhistone pre-mRNAs. As mentioned above, Ar-
temis can act as both an endonuclease and a 5-to-3 exonu-
clease, and it is possible that this rather unusual activity is also
shared by the structurally related CPSF-73 and RC-68 and
accounts for the postprocessing trimming of the downstream
cleavage product.
The most important similarity between cleavage that pre-
cedes polyadenylation and cleavage of histone pre-mRNAs is
generation of a hydroxyl group at the 3 end of the upstream
cleavage product typical of metal-mediated catalysis and the
resistance of both reactions to EDTA (17, 24, 25, 30, 44, 61, 63,
71). These features indicate that catalysis in both cases is in-
dependent of magnesium and might instead depend on zinc
ions. Metal-independent ribonucleases resistant to EDTA,
such as RNase A, generate a phosphate at the 3 end (5).
Interestingly, while cleavage preceding polyadenylation is in-
hibited by concentrations of EDTA higher than 5 mM (30, 60),
3 end processing of histone pre-mRNAs in mammalian (25)
and Drosophila nuclear extracts (17, 18) is extremely refractory
to EDTA and proceeds in the presence of 20 mM EDTA (Fig.
7A, lane 2) and can tolerate up to 40 mM EDTA without
significant loss of activity (not shown). While the different
resistances to EDTA of 3 end processing of histone pre-
mRNAs and 3 cleavage coupled to polyadenylation could
reflect general differences in composition of the respective
processing complexes, the failure of 20 mM EDTA to affect 3
end processing of histone pre-mRNA was difficult to reconcile
with the potential role for zinc in catalysis. To address this
concern, we tested whether S1 nuclease, a known zinc-depen-
dent enzyme that cleaves phosphodiester bonds in RNA and
DNA substrates and generates 3 OH in the cleavage products
(65), is also resistant to high concentrations of EDTA. As
shown in Fig. 7B, the ability of S1 nuclease to degrade RNA
was in fact stimulated by the presence of 2 and 20 mM EDTA
(lanes 3 and 4). The activity of calf intestinal phosphatase,
another zinc-dependent enzyme which hydrolyzes phos-
phoester bonds and generates 3 OH, was also unaffected by 20
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mM EDTA (not shown). These results demonstrated that zinc
ions are very tightly bound by both enzymes and are consistent
with catalysis of 3 end processing of histone pre-mRNAs by a
zinc-dependent enzyme. We used the anti-RC-68 antibody to
directly test whether RC-68 is required for 3 end processing of
histone pre-mRNAs in vitro. However, in spite of using various
conditions of immunodepletion, we were unable to sufficiently
remove RC-68 from the nuclear extract. The partial depletion
did not affect histone pre-mRNA processing.
Given the essential role of RC-68 in cell cycle progression in
HeLa cells it was not surprising that depletion of the Caeno-
rhabditis elegans RC-68 orthologue by RNAi leads to an early
lethal phenotype (our unpublished results with E. McCarthy,
B. Meier, and Y. Clejan). It has recently been shown that the
Arabidopsis orthologue of human RC-68, AtCPSF73-II, is also
essential for development (76). Intuitively, the presence of the
RC-68 in plants seems to contradict its involvement in the
processing of histone pre-mRNAs. In plants, histone mRNAs
are polyadenylated and are believed to be generated through
the regular cleavage and polyadenylation mechanism (58, 78).
However, the mechanism of cleavage and polyadenylation in
plants is poorly understood, and processing signals in pre-
mRNAs are only weakly conserved, suggesting that in plants
histone pre-mRNAs might comprise a separate class of cellular
pre-mRNAs that in spite of undergoing cleavage and polyad-
enylation requires a unique set of trans-acting factors. Future
studies should provide important clues to understanding the
function of the RC-68/RC-74 complex in both plants and an-
imals and links of RC-68 to cell cycle progression in human
cells
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